Dr. Annalisa Macagno
Abschluss: Dr. sc. nat., University of Zurich (Switzerland)
Zurich, Schweiz
Werdegang
Berufserfahrung von Annalisa Macagno
Bis heute 2 Jahre und 5 Monate, seit Mai 2022
Global Project Manager (part-time)
Roche Diagnostics International AG, Schweiz
Bis heute 4 Jahre und 5 Monate, seit Mai 2020
Strategy & Planning Advisor
Project-base
• Supporting the development of business strategies through evaluation of technologies, due diligence investigations, analysis of market and competition, and scouting of strategic alliances • Supporting the design of business plans with analyses of value creation, definition of milestones, preparation of project plans and design of exit strategies
1 Jahr und 6 Monate, Dez. 2018 - Mai 2020
Head of Science
Proteomedix AG
• Responsible for strategy development for new products (identifying new biomarkers, indications and technological platforms for new business opportunities in oncology). • Evaluating competitive positioning, developing market entry strategies and providing decision support to top management for business development and product launch. • Establishing biomarker plans, organising resources and managing portfolio of projects to qualify new biomarkers scientifically, technically and clinically.
3 Jahre und 4 Monate, Aug. 2015 - Nov. 2018
Head Assay Development
Proteomedix AG
• Led and managed portfolio of projects in oncology from biomarker selection to CE mark of IVD product. • Prepared and managed budget, reporting directly to CEO. • Led multi-disciplinary teams (research, regulatory, supply & manufacturing, clinical, medical affairs, commercial) for product development. • Supervised and coached the project team (3 direct reports), liaised KOL, managed external partners and CMOs. • Implemented compliance to regulatory requirement (ISO 13485) and managed risks.
4 Jahre und 9 Monate, Aug. 2011 - Apr. 2016
Scientific and Busines Advisor
Redbiotec and Redvax
• Analysed market opportunities and intellectual property landscape and supported management to define business strategies and project goals. • Integrated scientific research project proposal into a cost effective business plan for the preclinical development of a novel vaccine candidate for HSV. • Provided advise for the development of a preclinical cytomegalovirus vaccine candidate out-licensed to Pfizer and contributed to the creation of a proprietary technology platform for the design of vaccines.
2 Jahre und 1 Monat, Dez. 2011 - Dez. 2013
Head Antibody Discovery
ImmunoQure Research AG
• Set up company’s activities from inception until full capacity business, supporting the board to define goals and select projects (autoimmunity/inflammation). • Planned, managed and directed execution of all projects (budget, monitoring of prpogress to reach milestones). • Coordinated a cross-functional team of 30 experts (13 scientists and group leaders, 5 direct reports) at 6 international locations for advancing 4 programs to full pre-clinical characterization.
1 Jahr und 8 Monate, Apr. 2010 - Nov. 2011
Senior Scientist, Immunology
CT Atlantic AG
• Provided input in cancer immunobiology • Managed an oncology project and supervised the antibody technology team for the development of 8 lead antibodies for use in passive therapy or in combination with vaccine (subject of patent application WO 2012 / 163771). • Doubled the efficiency of cell technology and improved its robustness by successfully establishing quality assurance procedures. Cut down to 1/3 the time required for molecular cloning and complete sequence identification.
2 Jahre und 7 Monate, Sep. 2007 - März 2010
Staff Scientist
Institute for Research in Biomedicine
5 Jahre und 5 Monate, Apr. 2002 - Aug. 2007
Research Scientist (Postdoc)
Institute for Research in Biomedicine
3 Jahre und 6 Monate, Okt. 1998 - März 2002
Doctoral Student
Research Department of the Cantonal Hospital, St Gallen
Ausbildung von Annalisa Macagno
1 Jahr und 6 Monate, Jan. 2015 - Juni 2016
Business Administration (MBA)
University of Rochester
1 Jahr und 6 Monate, Jan. 2015 - Juni 2016
Executive MBA (EMBA)
University of Bern
3 Jahre und 6 Monate, Okt. 1998 - März 2002
Biochemistry
University of Zurich (Switzerland)
Biochemistry / Immunology
5 Jahre und 7 Monate, Sep. 1991 - März 1997
Biological Sciences, Biochemistry
University of Trieste (Italy)
Biomolecular orientation, Biochemistry
Sprachen
Englisch
Fließend
Italienisch
Muttersprache
Deutsch
Gut
Französisch
Grundlagen